Blog
Sharpton withdraws as eulogist at slain NYPD officer's funeral
The decision by the civil rights activist and long-time critic of the NYPD was announced in an open letter emailed to media, which cited reports criticizing his planned role at the funeral scheduled for Wednesday. It came hours after Holder’s fiancée was quoted in the New York Post as saying the officer detested Sharpton. In the Post story, Holder’s fiancée Mary Muhammad was quoted as saying on Monday, “He didn’t
A surging Clinton campaign tries to play it cool
For House Republicans, a crucial week
For House Republicans, a crucial week
Top U.S. drugmakers ride new products to strong results
By Bill Berkrot and Ransdell Pierson NEW YORK (Reuters) – Growing sales of expensive new cancer drugs and other newer medicines propelled top U.S. drugmakers Pfizer Inc , Merck & Co and Bristol-Myers Squibb Co to stronger-than-expected third-quarter profits. The results, announced on Tuesday, demonstrate that the “patent cliff” that had been hurting earnings as huge-selling drugs like Pfizer’s Lipitor and Bristol’s Plavix went generic is now well behind these
Top U.S. drugmakers ride new products to strong results
By Bill Berkrot and Ransdell Pierson NEW YORK (Reuters) – Growing sales of expensive new cancer drugs and other newer medicines propelled top U.S. drugmakers Pfizer Inc , Merck & Co and Bristol-Myers Squibb Co to stronger-than-expected third-quarter profits. The results, announced on Tuesday, demonstrate that the “patent cliff” that had been hurting earnings as huge-selling drugs like Pfizer’s Lipitor and Bristol’s Plavix went generic is now well behind these
Former lawmaker likely running to succeed Sacramento's basketball star mayor
By Sharon Bernstein SACRAMENTO, Calif. (Reuters) – California’s former top Democrat legislator hinted broadly on Tuesday that he will run for mayor of Sacramento, bringing political heft to a race to succeed Kevin Johnson, the former basketball star whose boosterism helped revitalize his home town Darrell Steinberg, a former president pro tem of the state senate and a onetime Sacramento City Council member, said in an email to supporters that
Former lawmaker likely running to succeed Sacramento's basketball star mayor
By Sharon Bernstein SACRAMENTO, Calif. (Reuters) – California’s former top Democrat legislator hinted broadly on Tuesday that he will run for mayor of Sacramento, bringing political heft to a race to succeed Kevin Johnson, the former basketball star whose boosterism helped revitalize his home town Darrell Steinberg, a former president pro tem of the state senate and a onetime Sacramento City Council member, said in an email to supporters that
Shire's eye drug data could strengthen bid for Baxalta, says CEO
By Paul Sandle LONDON (Reuters) – Shire reported positive results for a new eye drug on Tuesday, increasing the chances of lifitegrast reaching the market next year and boosting the London-listed group’s prospects as it tries to buy Baxalta. Chief Executive Flemming Ornskov said the news would help Shire’s attempt at an equity-based takeover of its U.S. rival to create a global leader in treatments for rare diseases. Lifitegrast significantly